Alpa Laboratories Limited (NSE:ALPA)

Market Cap	1.34B -38.6%
Revenue (ttm)	1.14B +18.9%
Net Income	116.09M -53.9%
EPS	5.52 -53.8%
Shares Out	21.04M
PE Ratio	11.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,044
Average Volume	21,370
Open	63.70
Previous Close	63.45
Day's Range	61.60 - 64.20
52-Week Range	60.22 - 120.50
Beta	0.53
RSI	38.57
Earnings Date	Feb 11, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 453
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALPA

Financial Performance

In fiscal year 2025, Alpa Laboratories's revenue was 1.12 billion, an increase of 3.41% compared to the previous year's 1.09 billion. Earnings were 195.03 million, an increase of 16.25%.